Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)

Search term: ovary cancer cell

Results 1 - 79 of 79
download as CSV
download all results as CSV
EC Number Recommended Name Source Tissue Commentary Reference
Show all pathways known for 1.1.1.141Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14115-hydroxyprostaglandin dehydrogenase (NAD+) ovary cancer cell - 725814
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase ovary cancer cell - 740542
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.66[histone H3]-trimethyl-L-lysine9 demethylase ovary cancer cell - 756531
Show all pathways known for 1.2.1.31Display the word mapDisplay the reaction diagram Show all sequences 1.2.1.31L-aminoadipate-semialdehyde dehydrogenase ovary cancer cell ovarian carcinoma, GI-102 675897
Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.1dihydropyrimidine dehydrogenase (NAD+) ovary cancer cell - 689367
Display the word mapDisplay the reaction diagram Show all sequences 1.6.3.1NAD(P)H oxidase (H2O2-forming) ovary cancer cell - 742556
Show all pathways known for 1.8.1.9Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.9thioredoxin-disulfide reductase ovary cancer cell inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells 686863
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.360[histone H3]-lysine79 N-trimethyltransferase ovary cancer cell - 754850
Show all pathways known for 2.2.1.1Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.1transketolase ovary cancer cell - 756500
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.48histone acetyltransferase ovary cancer cell - 703846, 756850
Show all pathways known for 2.3.1.50Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.50serine C-palmitoyltransferase ovary cancer cell strong overexpression of both SPT subunits 659621
Show all pathways known for 2.3.1.57Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.57diamine N-acetyltransferase ovary cancer cell C13 672937
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.85fatty-acid synthase system ovary cancer cell - 673222
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.85fatty-acid synthase system ovary cancer cell positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells 676254
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase ovary cancer cell GnT-III expression significantly increases ovarian cancer growth and metastasis and increases the expansion of the ovarian cancer stem cell (CSC) population 759483
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.150N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase ovary cancer cell EOC, GCNT3 expression is analyzed in a cohort of 56 EOC patients followed by a meta-analysis of more than one thousand patients 760171
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.212hyaluronan synthase ovary cancer cell - 692996
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.92(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase ovary cancer cell - 703916
Show all pathways known for 2.4.2.4Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.4thymidine phosphorylase ovary cancer cell tissue from 47 patiens with ovarian cancer after surgery. Significant higher enzyme activity in malignant tissue from ovarian cancer patients when compared to the control 658872
Display the reaction diagram Show all sequences 2.4.3.6N-acetyllactosaminide alpha-2,3-sialyltransferase ovary cancer cell - 758725
Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.60protein geranylgeranyltransferase type II ovary cancer cell significant overexpression of RabGGT-beta and RabGGT-alpha compared to normal tissue 658377
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1056-phosphofructo-2-kinase ovary cancer cell - 760902
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.153phosphatidylinositol-4,5-bisphosphate 3-kinase ovary cancer cell - 710173
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase ovary cancer cell EGF-R is moderately present in serous and mucinous borderline tumors and increases in adenocarcinomas, whereas TGF-alpha is moderately present 690295
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase ovary cancer cell Ron and Met are significantly coexpressed. Also another short form Ron is present 690303
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.2mitogen-activated protein kinase kinase ovary cancer cell impaired expression of MKK4 682214
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.2mitogen-activated protein kinase kinase ovary cancer cell weak expression 677913
Display the word mapDisplay the reaction diagram Show all sequences 2.7.4.21inositol-hexakisphosphate 5-kinase ovary cancer cell - 660992
Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.49RNA-directed DNA polymerase ovary cancer cell - 692539
Show all pathways known for 2.8.3.5Display the word mapDisplay the reaction diagram Show all sequences 2.8.3.53-oxoacid CoA-transferase ovary cancer cell - 762068
Show all pathways known for 3.1.3.4Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.4phosphatidate phosphatase ovary cancer cell - 709420
Show all pathways known for 3.1.3.4Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.4phosphatidate phosphatase ovary cancer cell shows reduced LPP1 activity 663994
Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.66phosphatidylinositol-3,4-bisphosphate 4-phosphatase ovary cancer cell - 731696
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.1phosphodiesterase I ovary cancer cell - 714113
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.2steryl-sulfatase ovary cancer cell - 716213
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.166heparanase ovary cancer cell - 731867
Display the word mapDisplay the reaction diagram Show all sequences 3.4.11.18methionyl aminopeptidase ovary cancer cell - 682206
Show all pathways known for 3.4.11.2Display the word mapDisplay the reaction diagram Show all sequences 3.4.11.2membrane alanyl aminopeptidase ovary cancer cell - 683301, 683556, 683561, 707970
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.106hepsin ovary cancer cell - 671835
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.106hepsin ovary cancer cell in ovarian cancer hepsin expression is mainly confined to the epithelial cells and not the adjacent stroma 698324
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.107peptidase Do ovary cancer cell high HtrA1 expression levels 683704
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.108HtrA2 peptidase ovary cancer cell benign tumor, borderline tumor, cancer, Krukenberg tumor 697363
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme ovary cancer cell - 677579, 682553, 683366
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme ovary cancer cell KLK7 is upregulated in epithelial ovarian carcinoma, expression of two different KLK7 transcripts, KLK7-253 and KLK7-181, simultaneously 707990
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme ovary cancer cell over-expressed in ovarian carcinoma tissues. Elevated KLK 7 mRNA expression in tumor tissue is associated with poorer prognosis for ovarian cancer patients 691153
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme ovary cancer cell overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells 664273
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme ovary cancer cell quantitative in situ protein expression analysis of 150 advanced-stage ovarian cancer samples of primary epithelial ovarian cancer patients, method development, overview 677579
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme ovary cancer cell short mRNA variant for KLK7 (alternative AUG, predicted protein N-terminally truncated and lacking catalytic histidine residue) expressed in normal ovary and in ovarian cancer 664272
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.118kallikrein 8 ovary cancer cell epithelial ovarian tumor 668282, 670447
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.119kallikrein 13 ovary cancer cell - 667393, 669632
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.35tissue kallikrein ovary cancer cell - 678522
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.35tissue kallikrein ovary cancer cell KLK4 and KLK11 679016
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.75Furin ovary cancer cell - 708162
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B10neurosin ovary cancer cell - 664273, 753300
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B10neurosin ovary cancer cell gene amplification is one mechanism for the overexpression of hK6 in ovarian cancer. High expression of hK6 protein in coexisting benign, borderline and invasive ovarian tumours is observed. The tumours also express high levels of kallikrein 6 mRNA 664465
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B10neurosin ovary cancer cell KLK6 is upregulated 679036
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B10neurosin ovary cancer cell KLK6 is upregulated. In benign tumour tissue, KLK6 expression is low 678956
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B10neurosin ovary cancer cell the enzyme is up-regulated in ovarian cancer 731397
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B12prostase ovary cancer cell - 664273, 681390
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B12prostase ovary cancer cell abundance of K4 comparable to that in breast carcinoma, higher expression as compared to malignant mesothelioma 686322
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B28fibroblast activation protein alpha subunit ovary cancer cell - 731043, 731767
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B39stratum corneum tryptic enzyme ovary cancer cell expression 670978
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B39stratum corneum tryptic enzyme ovary cancer cell high expression 670977
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B41kallikrein 10 ovary cancer cell - 682961
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B41kallikrein 10 ovary cancer cell significantly upregulated 670979
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B42hippostasin ovary cancer cell gene expression 668270
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B6prostasin ovary cancer cell enzyme levels significantly higher than those in control cells 673905
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.1cathepsin B ovary cancer cell epithelial, cathepsin B is significantly higher in patients older than compared with patients younger than 57 years of age 708376
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.34Legumain ovary cancer cell legumain is overexpressed in the majority of human solid tumours, including breast cancer, colorectal cancer, ovarian cancer, prostate cancer and gastric cancer 752851
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B1napsin ovary cancer cell the distribution of histotypes for 279 ovarian tumours are analysed 754994
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.7interstitial collagenase ovary cancer cell ovarian clear cell carcinoma cell 698145
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B7matrix metalloproteinase-26 ovary cancer cell no elevated MMP-26 expression level 710794
Show all pathways known for 4.2.1.11Display the word mapDisplay the reaction diagram Show all sequences 4.2.1.11phosphopyruvate hydratase ovary cancer cell ENOA is upregulated 714970
Show all pathways known for 4.3.2.9Display the word mapDisplay the reaction diagram Show all sequences 4.3.2.9gamma-glutamylcyclotransferase ovary cancer cell - 705761
Show all pathways known for 5.3.99.2Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.2Prostaglandin-D synthase ovary cancer cell human ovarian cancer cells. Prostaglandin synthase and testicular factor SOX9 are expressed at both RNA and protein levels in different types of ovarian tumors, while treatment of these cells with prostaglandin D2 can inhibit their growth and induce apoptosis 679017
Display the word mapDisplay the reaction diagram Show all sequences 5.6.2.3DNA 5'-3' helicase ovary cancer cell - 757877
Show all pathways known for 6.3.4.5Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.5argininosuccinate synthase ovary cancer cell AS mRNA increases 2- to 3fold by 24 h in both the IGROV-1 cell line, and a second ovarian cancer cell line OVCAR-3, following treatment with TNF-alpha. In contrast, although the ovarian cancer cell lines, PEO1 and SKOV-3, express AS in abundance, this is not TNF-a-inducible 674048
Show all pathways known for 6.3.4.5Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.5argininosuccinate synthase ovary cancer cell TNF-alpha induces prolonged expression of AS mRNA and protein in ovarian tumour cells, contrasting with short-lived expression of AS mRNA in the normal ovarian epithelial cells. AS mRNA is higher expressed in ovarian tumor tissue compared to normal ovarian tissue. Moreover, AS protein colocalises with TNF-alpha in ovarian cancer cells, with significantly higher levels of AS in malignant compared with normal ovarian tissue. 674048
Show all pathways known for 6.3.5.4Display the word mapDisplay the reaction diagram Show all sequences 6.3.5.4asparagine synthase (glutamine-hydrolysing) ovary cancer cell - 675914
Results 1 - 79 of 79
download as CSV
download all results as CSV